Pediatrix Medical Group, Inc. (NYSE:MD) Shares Sold by New York State Teachers Retirement System

New York State Teachers Retirement System lowered its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 7.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 126,574 shares of the company’s stock after selling 10,010 shares during the quarter. New York State Teachers Retirement System owned about 0.15% of Pediatrix Medical Group worth $1,467,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. nVerses Capital LLC acquired a new position in Pediatrix Medical Group in the second quarter valued at $31,000. Innealta Capital LLC acquired a new position in shares of Pediatrix Medical Group in the 2nd quarter valued at about $33,000. Nisa Investment Advisors LLC grew its holdings in shares of Pediatrix Medical Group by 47.2% during the 2nd quarter. Nisa Investment Advisors LLC now owns 4,755 shares of the company’s stock worth $36,000 after purchasing an additional 1,524 shares during the period. Canada Pension Plan Investment Board acquired a new stake in Pediatrix Medical Group during the 2nd quarter worth approximately $72,000. Finally, CWM LLC raised its holdings in Pediatrix Medical Group by 134.0% in the third quarter. CWM LLC now owns 6,427 shares of the company’s stock valued at $74,000 after buying an additional 3,681 shares during the period. 97.71% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Pediatrix Medical Group

In related news, CEO James D. Swift sold 11,100 shares of the business’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $10.79, for a total transaction of $119,769.00. Following the completion of the transaction, the chief executive officer now owns 170,001 shares in the company, valued at $1,834,310.79. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, Director Laura A. Linynsky sold 7,000 shares of Pediatrix Medical Group stock in a transaction that occurred on Tuesday, August 27th. The stock was sold at an average price of $11.16, for a total transaction of $78,120.00. Following the sale, the director now owns 30,805 shares of the company’s stock, valued at approximately $343,783.80. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO James D. Swift sold 11,100 shares of the stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $10.79, for a total value of $119,769.00. Following the completion of the transaction, the chief executive officer now directly owns 170,001 shares of the company’s stock, valued at $1,834,310.79. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 35,538 shares of company stock worth $373,664. 2.00% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several research firms have recently issued reports on MD. StockNews.com raised shares of Pediatrix Medical Group from a “sell” rating to a “hold” rating in a research report on Wednesday, August 7th. Truist Financial increased their price objective on shares of Pediatrix Medical Group from $13.00 to $16.00 and gave the company a “hold” rating in a research report on Monday, November 4th. UBS Group boosted their target price on shares of Pediatrix Medical Group from $10.50 to $16.50 and gave the stock a “neutral” rating in a research report on Tuesday, November 5th. Mizuho raised their price target on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the company a “neutral” rating in a report on Monday, November 4th. Finally, Jefferies Financial Group boosted their price objective on shares of Pediatrix Medical Group from $14.00 to $18.00 and gave the stock a “buy” rating in a report on Tuesday, November 5th. Five analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $16.10.

Pediatrix Medical Group Stock Down 1.7 %

Shares of Pediatrix Medical Group stock opened at $15.76 on Friday. The business has a 50-day moving average price of $12.08 and a 200 day moving average price of $9.64. Pediatrix Medical Group, Inc. has a fifty-two week low of $6.62 and a fifty-two week high of $16.41. The firm has a market cap of $1.35 billion, a P/E ratio of -5.15, a P/E/G ratio of 2.38 and a beta of 1.55. The company has a quick ratio of 1.38, a current ratio of 1.42 and a debt-to-equity ratio of 0.83.

Pediatrix Medical Group (NYSE:MD) last issued its quarterly earnings results on Friday, November 1st. The company reported $0.44 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.07. Pediatrix Medical Group had a positive return on equity of 12.79% and a negative net margin of 12.65%. The business had revenue of $511.20 million during the quarter, compared to the consensus estimate of $498.87 million. During the same period in the previous year, the business earned $0.29 EPS. The business’s quarterly revenue was up .9% on a year-over-year basis. On average, sell-side analysts forecast that Pediatrix Medical Group, Inc. will post 1.21 earnings per share for the current fiscal year.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.